Celiac Disease - Epidemiology Insights to 2023

  • ID: 4330794
  • Report
  • 40 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
Celiac Disease (CD) - Epidemiology Insights-2023 provides an overview of the Celiac Disease and current scenario of the disease in the 7MM, i.e., United States and EU5 countries (France, Germany, Italy, Spain and UK) and Japan. It also includes the global historical and forecasted epidemiological data for the total prevalent cases and diagnosed prevalent cases of Celiac Disease from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection.

Our forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to XXXX Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope:
  • The report covers the disease overview including pathophysiology, symptoms, diagnosis and disease management.
  • It focuses on the detailed historical number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for United States and the EU5 countries from 2013-2016.
  • The report also includes forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for US and the EU5 countries from 2017-2023.
Note: Very few studies have been conducted for celiac disease in Japan so a brief discussion about Japan’s Celiac Disease scenario has been discussed but no model has been provided.

Note: Please allow up to 48 hours for delivery of this report after payment has been made.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Report Introduction

2. Celiac Disease Overview
  • Celiac Disease Types
  • Non-Responsive or Refractory CD
  • Etiology
  • Symptoms
  • Diagnosis
  • Disease Management
  • Disease Treatment
  • Treatment of Celiac Disease
  • Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
  • Current Unmet Medical Needs
3. Epidemiology Parameters

4. Iceberg Model

5. Genetic Predisposition

6. Epidemiology &Patient Population
  • Total Diagnosed Prevalent Cases of Celiac Disease (2013-2023)
7. United States
  • Prevalent Cases of Celiac Disease in United States
8. European Five Countries
8.1 France
  • Prevalent Cases of Celiac Disease in France
8.2 Germany
  • Prevalent Cases of Celiac Disease in Germany
8.3 Italy
  • Prevalent Cases of Celiac Disease in Italy
8.4. Spain
  • Prevalent Cases of Celiac Disease in Spain
8.5 United Kingdom
  • Prevalent Cases of Celiac Disease in United Kingdom
9. Japan

10. Appendix

11. Report Methodology

12. Consulting Services

13. Disclaimer

14. About

List of Tables
Table 1: Total Diagnosed Prevalent Cases of Celiac Disease (2013-2023)
Table 2: Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Table 3: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 4: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 5: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 6: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 7: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)

List of Figures
Figure 1: Diagnostic Testing for Celiac Disease
Figure 2: Monitoring of Celiac Disease
Figure 3: Diagnosis and treatment of Refractory Celiac Disease
Figure 4: Iceberg model for Celiac disease epidemiology
Figure 5: Genetic predisposition in Celiac disease
Figure 6: Total Diagnosed Prevalent Cases of Celiac Disease (2013-2023)
Figure 7: Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Figure 8: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 9: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 10: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 11: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 12: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll